Thyrotoxic periodic paralysis in a Chinese population.

We retrospectively evaluated the characteristics of adult patients admitted with thyrotoxic hypokalaemic periodic paralysis in Hong Kong. From 1984 to 1993, 45 Chinese adult patients were admitted with acute limb weakness, plasma potassium < or = 3.5 mmol/l and thyrotoxicosis confirmed by laboratory investigations. All but one were male. Seventy-five percent of attacks occurred between 9pm and 9am. Half of the attacks occurred between July and October (49.1%), most commonly in August (20%). Mean (+/- SEM) plasma potassium on admission was 2.17 +/- 0.08 mmol/l (range 1.1-3.5). In 15 episodes (27.3%), plasma potassium on recovery exceeded 5.0 mmol/l, while in three episodes (5.5%), potassium exceeded 6.0 mmol/l. No patient had a positive family history of thyrotoxic periodic paralysis. Only 28.9% had a known history of thyrotoxicosis before their first presentation with periodic paralysis. Twenty-seven (60%) had clinical evidence of thyrotoxicosis. Although all were biochemically thyrotoxic, 11.4% had only a mild degree of thyrotoxicosis (suppressed thyroid-stimulating hormone, high free thyroxine, but normal free triiodothyronine). One quarter of the patients had a normal erythrocyte zinc concentration, indicating either a short history of thyrotoxicosis or transient thyrotoxicosis. The diagnosis of thyrotoxic hypokalaemic paralysis should always be considered in Chinese patients with acute muscle weakness, especially in young males. Absence of clinical thyrotoxicosis does not exclude the diagnosis. Plasma potassium should be monitored carefully during treatment to prevent rebound hyperkalaemia.

[1]  K. Anderson Hypokalemic periodic paralysis: a case study. , 1998, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[2]  J. Weissenbach,et al.  Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31–32 in three European families , 1994, Nature Genetics.

[3]  D. Cavan,et al.  The HLA association with Graves' disease is sex‐specific in Hong Kong Chinese subjects , 1994, Clinical endocrinology.

[4]  Ober Kp Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. , 1992 .

[5]  L. Binder,et al.  Hypokalemic paralyses: a review of the etiologies, pathophysiology, presentation, and therapy. , 1992, The American journal of emergency medicine.

[6]  S. Moralee,et al.  Metabolic stridor: bilateral vocal cord abductor paralysis secondary to hypokalaemia? , 1992, The Journal of Laryngology & Otology.

[7]  R. Swaminathan,et al.  In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. , 1991, BMJ.

[8]  K. Mori,et al.  Clinical utility of red blood cell carbonic anhydrase I and zinc concentrations in patients with thyroid diseases. , 1991, Metabolism: clinical and experimental.

[9]  G. L. Chin,et al.  Rhabdomyolysis associated with hypokalaemic periodic paralysis of renal tubular acidosis. , 1990, Singapore medical journal.

[10]  K. Yoshinaga,et al.  Erythrocyte zinc concentration in patients with subacute thyroiditis. , 1990, The Journal of clinical endocrinology and metabolism.

[11]  E. Taylor,et al.  Cation transport across lymphocyte plasma membranes in euthyroid and thyrotoxic men with and without hypokalaemic periodic paralysis. , 1990, Clinical science.

[12]  J. Mahabir,et al.  LOW SERUM TSH WITH NORMAL TOTAL THYROID HORMONE LEVELS: AN INDICATOR OF FREE T4 EXCESS , 1989, Clinical endocrinology.

[13]  G. François,et al.  Quadriplégie hypokaliémique et coma au cours d'une acidose tubulaire rénale , 1989 .

[14]  G. François,et al.  [Hypokalemic quadriplegia and coma in renal tubular acidosis]. , 1989, Annales francaises d'anesthesie et de reanimation.

[15]  H. Gharib,et al.  Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. , 1989, Archives of internal medicine.

[16]  P. Heckerling,et al.  Thyrotoxic periodic paralysis in a hispanic man. , 1988, Archives of internal medicine.

[17]  A. Spital,et al.  Disorders of internal potassium balance. , 1987, Seminars in nephrology.

[18]  J. Vannatta,et al.  Thyrotoxic hypokalemic periodic paralysis: report of four cases and review of the literature (1). , 1987, The Journal of the Oklahoma State Medical Association.

[19]  C. Wang,et al.  ASSOCIATION OF HLA ANTIGENS WITH THYROTOXIC GRAVES’ DISEASE AND PERIODIC PARALYSIS IN HONG KONG CHINESE , 1985, Clinical endocrinology.

[20]  C. Talbot,et al.  Surgery for thyrotoxicosis , 1983, The British journal of surgery.

[21]  J. Fisher Thyrotoxic periodic paralysis with ventricular fibrillation. , 1982, Archives of internal medicine.

[22]  R. Layzer Periodic paralysis and the sodium‐potassium pump , 1982, Annals of neurology.

[23]  S. Argov,et al.  The vanishing surgical treatment of Graves' disease: review of current literature and experience with 50 patients. , 1982, Current surgery.

[24]  R. Fauchet,et al.  HLA and Graves' disease: an association with HLA-DRw3. , 1980, The Journal of clinical endocrinology and metabolism.

[25]  J. Messenger,et al.  Cardiac dysfunction in a patient with familial hypokalemic periodic paralysis. , 1979, Chest.

[26]  O. Buruma,et al.  Hypokalaemic periodic paralysis and cardiomyopathy , 1978, Acta neurologica Scandinavica.

[27]  M. E. Charness Clinical conferences at The Johns Hopkins Hospital. Hypokalemic periodic paralysis. , 1978, The Johns Hopkins medical journal.

[28]  P. Yeo,et al.  HLA and thyrotoxic periodic paralysis. , 1978, British medical journal.

[29]  D. Morgan,et al.  RED-BLOOD-CELL COMPOSITION IN THYROID DISEASE , 1976, The Lancet.

[30]  T. Maren,et al.  Acetazolamide treatment of hypokalemic periodic paralysis. Probable mechanism of action. , 1975, Archives of neurology.

[31]  R. Yeung,et al.  Thyrotoxic periodic paralysis. Effect of propranolol. , 1974, The American journal of medicine.

[32]  R. Eaton,et al.  Thyrotoxicosis and periodic paralysis: improvement with beta blockade. , 1974, Annals of internal medicine.

[33]  F. Norris,et al.  Studies in thyrotoxic periodic paralysis. , 1971, Journal of the neurological sciences.

[34]  W. Engel,et al.  Acetazolamide treatment of hypokalemic periodic paralysis. Prevention of attacks and improvement of persistent weakness. , 1970, Annals of internal medicine.

[35]  W. Engel,et al.  Thyrotoxic periodic paralysis. , 1969, The American journal of medicine.

[36]  A. Mcfadzean,et al.  Periodic paralysis complicating thyrotoxicosis in Chinese. , 1967, British medical journal.

[37]  R. Nordyke,et al.  Hypokalemic periodic paralysis. Experimental precipitation with sodium liothyronine. , 1966, JAMA.

[38]  Z. Lewitus [Treatment of hyperthyroidism]. , 1965, Dapim refuiim. Folia medica.

[39]  R. L. Jackman,et al.  HYPERTHYROIDISM AND PERIODIC PARALYSIS. , 1964, Archives of internal medicine.

[40]  E. Satoyoshi,et al.  Periodic paralysis in hyperthyroidism , 1963, Neurology.

[41]  R. Aitken,et al.  Muscular Weakness After Prolonged Ingestion of Thyroid , 1962, British medical journal.

[42]  A. Engel Thyroid function and periodic paralysis. , 1961, The American journal of medicine.

[43]  M. Irie,et al.  The association of periodic paralysis and hyperthyroidism in Japan. , 1957, The Journal of clinical endocrinology and metabolism.

[44]  G. Crile The treatment of hyperthyroidism , 1947, Canadian Medical Association journal.